Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Deutsch AJ, Rinner B, Wenzl K, Pichler M, Troppan K, Steinbauer E, Schwarzenbacher D, Reitter S, Feichtinger J, Tierling S, Prokesch A, Scheideler M, Krogsdam A, Thallinger GG, Schaider H, Beham-Schmid C, Neumeister P. Deutsch AJ, et al. Among authors: wenzl k. Blood. 2014 Apr 10;123(15):2367-77. doi: 10.1182/blood-2013-08-518878. Epub 2014 Feb 19. Blood. 2014. PMID: 24553175 Free article.
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan KT, Schlick K, Deutsch A, Melchardt T, Egle A, Stojakovic T, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Pichler M. Troppan KT, et al. Among authors: wenzl k. Br J Cancer. 2014 Jul 8;111(1):55-60. doi: 10.1038/bjc.2014.277. Epub 2014 May 29. Br J Cancer. 2014. PMID: 24874478 Free PMC article.
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan KT, Melchardt T, Deutsch A, Schlick K, Stojakovic T, Bullock MD, Reitz D, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Egle A, Pichler M. Troppan KT, et al. Among authors: wenzl k. Eur J Haematol. 2015 Dec;95(6):538-44. doi: 10.1111/ejh.12529. Epub 2015 Mar 26. Eur J Haematol. 2015. PMID: 25677782
Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
Troppan K, Hofer S, Wenzl K, Lassnig M, Pursche B, Steinbauer E, Wiltgen M, Zulus B, Renner W, Beham-Schmid C, Deutsch A, Neumeister P. Troppan K, et al. Among authors: wenzl k. PLoS One. 2015 Apr 9;10(4):e0123922. doi: 10.1371/journal.pone.0123922. eCollection 2015. PLoS One. 2015. PMID: 25856582 Free PMC article.
Molecular Pathogenesis of MALT Lymphoma.
Troppan K, Wenzl K, Neumeister P, Deutsch A. Troppan K, et al. Among authors: wenzl k. Gastroenterol Res Pract. 2015;2015:102656. doi: 10.1155/2015/102656. Epub 2015 Apr 1. Gastroenterol Res Pract. 2015. PMID: 25922601 Free PMC article. Review.
33 results